Biomea Fusion(BMEA) - 2025 Q4 - Annual Results

Exhibit 99.1 Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights SAN CARLOS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ("Biomea" or "Biomea Fusion" or "the Company") (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today reported its financial results for the full year ended December 31, 2025 and provided a business update. "The past year was a year of execution for Biomea as we advanced from validating the menin pathway in primarily preclinical ...